SPOTLIGHT -
Pharmaceutical Executive
Planning fundamentals map the route to increased worldwide market share.
Pharma Pulse 3/28/24: The Fight for AI Talent, Atopic Dermatitis and Mental Health & more
The latest news for pharma industry insiders.
Gen-Z Influence on Pharma M&A
Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
Winrevair is the first FDA-approved activin signaling inhibitor therapy for pulmonary arterial hypertension.
Recent Licensing Agreement Poised to Advance Company ADC
In an interview with PharmExec Associate Editor Don Tracy, Jingsong Wang discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033.
Stakeholder Capitalism: Q&A with Meg Alexander, Chief Strategy Officer at Ovid Therapeutics (Part 2)
Alexander continues her conversation, touching on topics like disinformation and diversity in clinical trials.
Pharma Pulse 3/27/24: Patients Hate ‘Forever’ Drugs—Is Wegovy Different? Low Melatonin Can Increase Risk of Neurological Disorders & more